by Richard Daverman, PhD
February 18, 2014 -- According to reports, Citic Private Equity Funds Management is seeking funds from China banks to buy Biosensors International Group, a China cardiovascular device company that is listed in Singapore. Its market capitalization is $1.2 billion. Citic Private Equity paid $312.2 million to buy a 22% stake in Biosensors last November from Shandong Weigao Group. Biosensors’ stock price has been trending lower. More details....
Help employers find you! Check out all the jobs and post your resume.
